Celula China Med-Technology Co., Ltd. is a high-tech enterprise with advanced diagnostic technologies. The company established headquarter in Chengdu 2013, and subsidiaries in Shanghai, Zhuhai/Hengqin, Beijing and San Diego. It has more than 5,000 square-meter facility for R&D, commercial operation and close to 100 employees with multidisciplinary technical background and commercial experiences. Through years of technology development in both US and China, the company has successfully launched miniaturized Sparrow flow cytometer and IVD reagent kits for reproductive health, immunology and other important diseases. The product is designed for all levels of hospitals and clinical laboratories in China. Celula China has also developed a novel NIPT technology based on targeted sequencing. Its product has advantages in higher accuracy, expanded test content and lower cost, which can be applied to all pregnant women in earlier gestational weeks.
Celula China will continue technology innovations, provide the most complete and cost effective IVD products.